EquityZen Growth Technology Fund LLC - Series 2060
Raised
$573K
Investors
29
Min Invest
$5,005
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2060 is a Delaware-organized pooled investment fund filed by EquityZen Advisors LLC and Phil Haslett under Rule 506(b) and Section 3(c). The entity raised $573K from 29 investors with a $5K minimum investment. It is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles.
This pre-IPO fund follows the typical EquityZen series structure with Rule 506(b) and 3(c) exemptions. The $5K minimum investment positions it in the retail-accessible tier of private placements, consistent with platform democratization models serving individual accredited investors rather than institutional LPs.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
